Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nadishka Jayawardena, Laura N Burga, John T Poirier & Mihnea Bostina. (2019) Virus–Receptor Interactions: Structural Insights For Oncolytic Virus Development. Oncolytic Virotherapy 8, pages 39-56.
Read now
Read now
Marianne M Stanford & Grant McFadden. (2007) Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer. Expert Opinion on Biological Therapy 7:9, pages 1415-1425.
Read now
Read now
Michael Ulrich-Vinther. (2007) Gene therapy methods in bone and joint disorders. Acta Orthopaedica 78:sup325, pages 2-64.
Read now
Read now
Gorben P Pijlman, Andreas Suhrbier & Alexander A Khromykh. (2006) Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications. Expert Opinion on Biological Therapy 6:2, pages 135-145.
Read now
Read now
Articles from other publishers (54)
Mobarakeh Ajam-Hosseini, Fatemeh Akhoondi & Mohammad Doroudian. (2023) Nano based-oncolytic viruses for cancer therapy. Critical Reviews in Oncology/Hematology 185, pages 103980.
Crossref
Crossref
Xuedan Li, Yang Le, Zhegang Zhang, Xuanxuan Nian, Bo Liu & Xiaoming Yang. (2023) Viral Vector-Based Gene Therapy. International Journal of Molecular Sciences 24:9, pages 7736.
Crossref
Crossref
Duygu Sari-Ak, Omar Alomari, Raghad Shomali, Jackwee Lim & Deepak Thimiri Govinda Raj. (2022) Advances in CRISPR-Cas9 for the Baculovirus Vector System: A Systematic Review. Viruses 15:1, pages 54.
Crossref
Crossref
Lingling Dai & Lizhong Du. (2022) Genes in pediatric pulmonary arterial hypertension and the most promising BMPR2 gene therapy. Frontiers in Genetics 13.
Crossref
Crossref
Xinjun Liu, Jian Zhao, Xiaopeng Li, Fengxue Lao & Min Fang. (2022) Design Strategies and Precautions for Using Vaccinia Virus in Tumor Virotherapy. Vaccines 10:9, pages 1552.
Crossref
Crossref
Mingyu Ye, Markus Keicher, Ivaylo Gentschev & Aladar A. Szalay. (2021) Efficient Selection of Recombinant Fluorescent Vaccinia Virus Strains and Rapid Virus Titer Determination by Using a Multi-Well Plate Imaging System. Biomedicines 9:8, pages 1032.
Crossref
Crossref
Clévio Nóbrega, Liliana Mendonça & Carlos A. MatosClévio Nóbrega, Liliana Mendonça & Carlos A. Matos. 2020. A Handbook of Gene and Cell Therapy. A Handbook of Gene and Cell Therapy
39
90
.
Iman Arabipour, Jafar Amani, Seyed Ali Mirhosseini & Jafar Salimian. (2019) The study of genes and signal transduction pathways involved in mustard lung injury: A gene therapy approach. Gene 714, pages 143968.
Crossref
Crossref
Susanne G. Warner, Sang-In Kim, Shyambabu Chaurasiya, Michael P. O’Leary, Jianming Lu, Venkatesh Sivanandam, Yanghee Woo, Nanhai G. Chen & Yuman Fong. (2019) A Novel Chimeric Poxvirus Encoding hNIS Is Tumor-Tropic, Imageable, and Synergistic with Radioiodine to Sustain Colon Cancer Regression. Molecular Therapy - Oncolytics 13, pages 82-92.
Crossref
Crossref
G. Bohelay & T.-A. Duong. (2019) Infections humaines à poxvirus. Annales de Dermatologie et de Vénéréologie 146:5, pages 387-398.
Crossref
Crossref
Carmela Di Gioia, Ming Yuan & Yaohe Wang. 2019. Vaccinia Virus. Vaccinia Virus
109
117
.
Saeedeh Ebrahimi, Ali Teimoori, Hashem Khanbabaei & Maryam Tabasi. (2018) Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome. Reviews in Medical Virology 29:1.
Crossref
Crossref
Zong Sheng Guo, Zuqiang Liu, Magesh Sathaiah, Jiahu Wang, Roshni Ravindranathan, Eun Kim, Shaohua Huang, Thomas W. Kenniston, John C. Bell, Herbert J. ZehIIIIII, Lisa H. Butterfield, Andrea Gambotto & David L. Bartlett. (2017) Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus. Molecular Therapy - Methods & Clinical Development 7, pages 112-122.
Crossref
Crossref
Feng Yin, Bobo Gu, Yining Lin, Nishtha Panwar, Swee Chuan Tjin, Junle Qu, Shu Ping Lau & Ken-Tye Yong. (2017) Functionalized 2D nanomaterials for gene delivery applications. Coordination Chemistry Reviews 347, pages 77-97.
Crossref
Crossref
G. Bohelay & T.-A. Duong. (2017) Infecciones por poxvirus en humanos. EMC - Dermatología 51:3, pages 1-9.
Crossref
Crossref
J. Patrick Condreay, Thomas A. Kost & Claudia A. Mickelson. 2017. Biological Safety. Biological Safety
221
246
.
Dolan SondhiKatie M. StilesBishnu P. DeRonald G. Crystal. (2017) Genetic Modification of the Lung Directed Toward Treatment of Human Disease. Human Gene Therapy 28:1, pages 3-84.
Crossref
Crossref
Ming Yuan, Eika Webb, Nicholas Lemoine & Yaohe Wang. (2016) CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic Viruses. Viruses 8:3, pages 72.
Crossref
Crossref
Ming Yuan, Wensheng Zhang, Jun Wang, Chadwan Al Yaghchi, Jahangir Ahmed, Louisa Chard, Nick R. Lemoine & Yaohe Wang. (2015) Efficiently Editing the Vaccinia Virus Genome by Using the CRISPR-Cas9 System. Journal of Virology 89:9, pages 5176-5179.
Crossref
Crossref
Z Guo, J McCart & David Bartlett. 2015. Gene and Cell Therapy. Gene and Cell Therapy
133
156
.
Ming Yuan, Xuefei Gao, Louisa S Chard, Zarah Ali, Jahangir Ahmed, Yunqing Li, Pentao Liu, Nick R Lemoine & Yaohe Wang. (2015) A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9. Molecular Therapy - Methods & Clinical Development 2, pages 15035.
Crossref
Crossref
Claudia Peitzsch, Monica Cojoc, Ina Kurth & Anna Dubrovska. 2015. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology. Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology
89
130
.
Hadeel Khallouf, Agnieszka Grabowska & Angelika Riemer. (2014) Therapeutic Vaccine Strategies against Human Papillomavirus. Vaccines 2:2, pages 422-462.
Crossref
Crossref
Evangelos Pazarentzos & Nicholas D. Mazarakis. 2014. Anticancer Genes. Anticancer Genes
255
280
.
Nermin Raafat, Charlotte Sadowski‐Cron, Chantal Mengus, Michael Heberer, Giulio C. Spagnoli & Paul Zajac. (2012) Preventing vaccinia virus class‐I epitopes presentation by HSV‐ICP47 enhances the immunogenicity of a TAP‐independent cancer vaccine epitope. International Journal of Cancer 131:5.
Crossref
Crossref
Nahlah M Almansour, Elena Pirogova, Peter J Coloe, Irena Cosic & Taghrid S Istivan. (2012) Investigation of cytotoxicity of negative control peptides versus bioactive peptides on skin cancer and normal cells: a comparative study. Future Medicinal Chemistry 4:12, pages 1553-1565.
Crossref
Crossref
M. P. Limberis. (2012) Phoenix rising: gene therapy makes a comeback. Acta Biochimica et Biophysica Sinica 44:8, pages 632-640.
Crossref
Crossref
M Sathaiah, P Thirunavukkarasu, M E O'Malley, M A Kavanagh, R Ravindranathan, F Austin, Z S Guo & D L Bartlett. (2011) Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer. Cancer Gene Therapy 19:3, pages 192-201.
Crossref
Crossref
Liu Xin-Yuan, Wen-Lin Huang, Qi-Jun Qian, Wei-Guo Zou, Zi-Lai Zhang, Liang Chu, Kang-Jian Zhang, Li-Li Zhao, Yan-Hong Zhang, Song-Bo Qiu, Zhen-Wei Zhang, Tian Xiao, Jun-Kai Fan, Na Wei, Xin-Ran Liu, Xin Cao, Jin-Fa Gu, Rui-Cheng Wei, Miao Ding & Shuai Wu. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy
33
83
.
Yuan ZhaoYan Fei AdamsMichael Croft. (2011) Preferential Replication of Vaccinia Virus in the Ovaries is Independent of Immune Regulation Through IL-10 and TGF-β. Viral Immunology 24:5, pages 387-396.
Crossref
Crossref
James R TysomePengju WangGhassan AlusiArnaud BriatRathi GangeswaranJiwei WangVipul BhaktaIstvan FodorNick R. LemoineYaohe Wang. (2011)
Lister Vaccine Strain of Vaccinia Virus Armed with the Endostatin–Angiostatin Fusion Gene: An Oncolytic Virus Superior to
dl
1520 (ONYX-015) for Human Head and Neck Cancer
. Human Gene Therapy 22:9, pages 1101-1108.
Crossref
Crossref
Elizabeth M Hadac, Elizabeth J Kelly & Stephen J Russell. (2011) Myeloma Xenograft Destruction by a Nonviral Vector Delivering Oncolytic Infectious Nucleic Acid. Molecular Therapy 19:6, pages 1041-1047.
Crossref
Crossref
R.A. Schwendener & Herbert Schott. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia
1
24
.
J R Tysome, A Briat, G Alusi, F Cao, D Gao, J Yu, P Wang, S Yang, Z Dong, S Wang, L Deng, J Francis, T Timiryasova, I Fodor, N R Lemoine & Y Wang. (2009) Lister strain of vaccinia virus armed with endostatin–angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer. Gene Therapy 16:10, pages 1223-1233.
Crossref
Crossref
Larry Hanson. 2009. Handbook of Nucleic Acid Purification. Handbook of Nucleic Acid Purification.
W Hu, W Hofstetter, W Guo, H Li, A Pataer, H H Peng, Z S Guo, D L Bartlett, A Lin, S G Swisher & B Fang. (2008) JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase. Cancer Gene Therapy 15:9, pages 616-624.
Crossref
Crossref
Z. Sheng Guo, Stephen H. Thorne & David L. Bartlett. (2008) Oncolytic virotherapy: Molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1785:2, pages 217-231.
Crossref
Crossref
S Chalikonda, M H Kivlen, M E O'Malley, X D Dong, J A McCart, M C Gorry, X-Y Yin, C K Brown, H J ZehIIIIII, Z S Guo & D L Bartlett. (2007) Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene. Cancer Gene Therapy 15:2, pages 115-125.
Crossref
Crossref
Marianne M Stanford, Mae Shaban, John W Barrett, Steven J Werden, Philippe-Alexandre Gilbert, Joe Bondy-Denomy, Lisa MacKenzie, Kevin C Graham, Ann F Chambers & Grant McFadden. (2008) Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo. Molecular Therapy 16:1, pages 52-59.
Crossref
Crossref
S Yang, Z S Guo, M E O'Malley, X Yin, H J Zeh & D L Bartlett. (2007) A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Gene Therapy 14:8, pages 638-647.
Crossref
Crossref
Marianne M. Stanford, John W. Barrett, Steven H. Nazarian, Steven Werden & Grant McFadden. (2007) Oncolytic Virotherapy Synergism with Signaling Inhibitors: Rapamycin Increases Myxoma Virus Tropism for Human Tumor Cells. Journal of Virology 81:3, pages 1251-1260.
Crossref
Crossref
Andrea Marrari, Manuela Iero, Lorenzo Pilla, Sergio Villa, Roberto Salvioni, Riccardo Valdagni, Giorgio Parmiani & Licia Rivoltini. (2006) Vaccination therapy in prostate cancer. Cancer Immunology, Immunotherapy 56:4, pages 429-445.
Crossref
Crossref
Sricharan Chalikonda & David L. Bartlett. 2007. Gene Therapy for Cancer. Gene Therapy for Cancer
73
85
.
David S. Strayer, Lokesh Agrawal, Pierre Cordelier, Bianling Liu, Jean-Pierre Louboutin, Elena Marusich, Hayley J. McKee, Carmen N. NiGongyi Ren & Marlene S. Strayer. (2006) Long-term gene expression in dividing and nondividing cells using SV40-derived vectors. Molecular Biotechnology 34:2, pages 257-270.
Crossref
Crossref
Thomas A. Kost, Condreay J. Patrick & Claudia A. Mickelson. 2006. Biological Safety. Biological Safety
509
530
.
Jan Willem B. de GrootThera P. LinksJohn T. M. PlukkerCornelis J. M. Lips & Robert M. W. Hofstra. (2006) RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors. Endocrine Reviews 27:5, pages 535-560.
Crossref
Crossref
Collin R. Brooks, Tim Elliott, Peter Parham & Salim I. Khakoo. (2006) The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells. The Journal of Immunology 176:2, pages 1141-1147.
Crossref
Crossref
Z. Sheng Guo, Arpana Naik, Mark E. O'Malley, Petar Popovic, Richard Demarco, Yun Hu, Xiaoyu Yin, Shuting Yang, Herbert J. Zeh, Bernard Moss, Michael T. Lotze & David L. Bartlett. (2005)
The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes
SPI-1
and
SPI-2
. Cancer Research 65:21, pages 9991-9998.
Crossref
Crossref
Manuel Schmidt, Barbara Volz & Burghardt Wittig. 2005. Modern Biopharmaceuticals. Modern Biopharmaceuticals
183
211
.
Dan Laheru & Elizabeth M. Jaffee. (2005) Immunotherapy for pancreatic cancer — science driving clinical progress. Nature Reviews Cancer 5:6, pages 459-467.
Crossref
Crossref
Marianne M. Stanford & Grant McFadden. (2005) The ?supervirus?? Lessons from IL-4-expressing poxviruses. Trends in Immunology 26:6, pages 339-345.
Crossref
Crossref
Grant McFadden. (2005) Poxvirus tropism. Nature Reviews Microbiology 3:3, pages 201-213.
Crossref
Crossref
Yuqiao Shen & John Nemunaitis. (2005) Fighting Cancer with Vaccinia Virus: Teaching New Tricks to an Old Dog. Molecular Therapy 11:2, pages 180-195.
Crossref
Crossref
J.B. Johnston, Steven H. Nazarian, Renato Natale & Grant McFadden. (2005) Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. Virology 332:1, pages 235-248.
Crossref
Crossref